back to explore
Centene Corp logo

CNC

Centene Corp
NEW YORK STOCK EXCHANGE, INC.· Health Care· US· IPO 2001-12-13
$67.48
+0.95 (+1.43%)
last quote
Want the full multi-source brief on CNC?
The agent pulls regulatory filings, news flow, prediction-market pricing, and macro context — then synthesizes what's not yet in the price.
open in agent
Today
Open
$67.48
High
$67.49
Low
$66.11
Previous close
$66.53
Fundamentals
Market cap
$32.85B
P/E (TTM)
—
P/S (TTM)
0.17x
P/B
1.01x
Gross margin
7.18%
Operating margin
-3.68%
Net margin
-3.25%
Rev growth (YoY)
17.02%
EPS growth (YoY)
—
ROE
-24.03%
52W high
$72.50
52W low
$31.63
Beta
1.04x
Recent news
2026-10-28 → 2026-11-04
Yahoo · 3h
Zacks.com featured highlights include APA, T-Mobile, BP and Centene
As market volatility intensifies the value-versus-growth debate, APA and three other GARP stocks combine attractive valuations with sustainable earnings growth potential.
Yahoo · 17h
4 GARP Stocks to Buy Now as Volatility Fuels Value vs. Growth Debate
Discover four GARP stocks, APA, T-Mobile, BP and Centene, that combine attractive valuations with sustainable earnings growth potential amid market volatility.
Yahoo · 20h
Election Odds Favor a Blue Wave. These Stocks Could Pop.
Wall Street expects today's midterm elections to end with a Democratic sweep leaving a divided government.
Yahoo · 1d
Will UNH's Optum Insight Spending Translate Into Profit Growth?
UnitedHealth is scaling AI solutions across Optum Insight to boost efficiency, improve claims processing and drive long-term growth despite rising costs.
ChartMill · 1d
S&P 500 Opening Gap Movers for November 2, 2026
S&P 500 stocks with notable opening gaps on November 2, 2026, including gap-up names such as IDXX, UAL and MAR, and gap-down names such as LITE, ORCL and MRVL.
Benzinga · 1d
Truist Securities Reiterates Buy on Centene, Raises Price Target to $82
Truist Securities analyst David Macdonald reiterates Centene (NYSE:CNC) with a Buy and raises the price target from $80 to $82.
Yahoo · 4d
CNC Q3 deep dive: Medicare and Marketplace margin gains drive improved outlook
Health coverage company Centene (NYSE:CNC) announced better-than-expected revenue in Q3 2026, with sales up 1.9% year on year to $50.65 billion. The company’s full-year revenue guidance of $198.5 billion at the midpoint came in 1.3% above analysts’ estimates. Its non-GAAP profit of $0.58 per share was significantly above analysts’ consensus estimates.
Benzinga · 4d
Wells Fargo Maintains Equal-Weight on Centene, Raises Price Target to $75
Wells Fargo analyst Stephen Baxter maintains Centene (NYSE:CNC) with a Equal-Weight and raises the price target from $69 to $75.
This is the free preview

The agent layer adds regulatory-language drift detection, cross-venue prediction-market signals, macro overlays, programmable alert rules, overnight briefs, and a grounding verifier on every claim. 7-day Pro trial, no card required.

Start the trial